Evidence map›Paper›PMID 35143327›Full record

ArticleCirculation2022

Second Heart Field-Derived Cells Contribute to Angiotensin II-Mediated Ascending Aortopathies.

Hisashi Sawada, Yuriko Katsumata, Hideyuki Higashi, Chen Zhang, Yanming Li, Stephanie Morgan, Lang H Lee, Sasha A Singh, Jeff Z Chen, Michael K Franklin and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Angiotensin II Induces Abdominal Aortic Branch Aneurysms inArteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Mitochondrial NADNature cardiovascular research · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Hisashi SawadaSaha Cardiovascular Research Center (H.S., J.Z.C., M.K.F., J.J.M., D.A.H., D.L.R., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0003-0017-6236
Yuriko KatsumataCollege of Medicine, Department of Biostatistics, College of Public Health (Y.K.), University of Kentucky, Lexington.ORCID 0000-0002-0188-8094
Chen ZhangDivision of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX (C.Z., Y.L., Y.H.S., S.A.L.).ORCID 0000-0002-3156-1391
Yanming LiDivision of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX (C.Z., Y.L., Y.H.S., S.A.L.).ORCID 0000-0002-8213-9166
Stephanie MorganCenter for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (H.H., S.M., L.H.L., S.A.S., M.A.).ORCID 0000-0002-7969-3721
Lang H LeeCenter for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (H.H., S.M., L.H.L., S.A.S., M.A.).ORCID 0000-0002-9684-160X
Sasha A SinghCenter for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (H.H., S.M., L.H.L., S.A.S., M.A.).ORCID 0000-0003-0929-3164
Jeff Z ChenSaha Cardiovascular Research Center (H.S., J.Z.C., M.K.F., J.J.M., D.A.H., D.L.R., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0002-2893-1523
Michael K FranklinSaha Cardiovascular Research Center (H.S., J.Z.C., M.K.F., J.J.M., D.A.H., D.L.R., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0003-4993-0164
Jessica J MoorleghenSaha Cardiovascular Research Center (H.S., J.Z.C., M.K.F., J.J.M., D.A.H., D.L.R., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0002-2556-6719
Deborah A HowattSaha Cardiovascular Research Center (H.S., J.Z.C., M.K.F., J.J.M., D.A.H., D.L.R., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0002-0078-092X
Debra L RateriSaha Cardiovascular Research Center (H.S., J.Z.C., M.K.F., J.J.M., D.A.H., D.L.R., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0002-3925-648X
Ying H ShenDivision of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX (C.Z., Y.L., Y.H.S., S.A.L.).ORCID 0000-0003-4119-115X
Scott A LeMaireDivision of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX (C.Z., Y.L., Y.H.S., S.A.L.).ORCID 0000-0002-8736-4266
Masanori AikawaCenter for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (H.H., S.M., L.H.L., S.A.S., M.A.).ORCID 0000-0002-9275-2079
Mark W MajeskyDepartments of Laboratory Medicine and Pathology (M.W.M.), University of Washington, Seattle.ORCID 0000-0003-4267-6220
Hong S LuSaha Cardiovascular Research Center (H.S., J.Z.C., M.K.F., J.J.M., D.A.H., D.L.R., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0002-0577-2558
Alan DaughertySaha Cardiovascular Research Center (H.S., J.Z.C., M.K.F., J.J.M., D.A.H., D.L.R., H.S.L., A.D.), University of Kentucky, Lexington.ORCID 0000-0003-2093-3775
University of Kentucky · USBrigham and Women's Hospital · USHouston Methodist · USUniversity of Washington · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Reprogramming of mature smooth muscle cells to vascular progenitor cellsR01HL121877 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MARK W. MAJESKY, Mary CM Weiser-Evans · 2015 to 2026
$7.8M
Determinants of Aorta HeterogeneityR35HL155649 · NHLBI · UNIVERSITY OF KENTUCKY · PI Alan Daugherty · 2021 to 2026
$5.3M
Pro-inflammatory activation of human macrophages regulated by lncRNAsR01HL149302 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, MASANORI · 2019 to 2022
$2.9M
Adventitial-medial interactions in thoracic aortic diseasesR01HL133723 · NHLBI · UNIVERSITY OF KENTUCKY · PI DAUGHERTY, ALAN · 2016 to 2019
$2.9M
PARP9 and PARP14 in atherosclerosisR01HL126901 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, MASANORI · 2016 to 2019
$2.4M
Pro-inflammatory Pyroptotic Cell Death in Aortic DegenerationR01HL158157 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LEMAIRE, SCOTT A, SHEN, YING H · 2021 to 2024
$2.4M
Mechanisms of renin angiotensin modulation in thoracic aortic aneurysmsF30HL143943 · NHLBI · UNIVERSITY OF KENTUCKY · PI CHEN, JEFF ZHEYING · 2019 to 2021
$130k
NCATS NIH HHS UL1 TR001998NHLBI NIH HHS F30 HL143943NHLBI NIH HHS R01 HL121877NHLBI NIH HHS R01 HL126901NHLBI NIH HHS R01 HL133723NHLBI NIH HHS R01 HL149302NHLBI NIH HHS R01 HL158157NHLBI NIH HHS R35 HL155649
6 · The paper itself

Abstract

backgroundThe ascending aorta is a common location for aneurysm and dissection. This aortic region is populated by a mosaic of medial and adventitial cells that are embryonically derived from either the second heart field (SHF) or the cardiac neural crest. SHF-derived cells populate areas that coincide with the spatial specificity of thoracic aortopathies. The purpose of this study was to determine whether and how SHF-derived cells contribute to ascending aortopathies.

methodsAscending aortic pathologies were examined in patients with sporadic thoracic aortopathies and angiotensin II (AngII)-infused mice. Ascending aortas without overt pathology from AngII-infused mice were subjected to mass spectrometry-assisted proteomics and molecular features of SHF-derived cells were determined by single-cell transcriptomic analyses. Genetic deletion of either

resultsPathologies in human ascending aortic aneurysmal tissues were predominant in outer medial layers and adventitia. This gradient was mimicked in mouse aortas after AngII infusion that was coincident with the distribution of SHF-derived cells. Proteomics indicated that brief AngII infusion before overt pathology occurred evoked downregulation of smooth muscle cell proteins and differential expression of extracellular matrix proteins, including several LRP1 ligands. LRP1 deletion in SHF-derived cells augmented AngII-induced ascending aortic aneurysm and rupture. Single-cell transcriptomic analysis revealed that brief AngII infusion decreased

conclusionsSHF-derived cells exert a critical role in maintaining vascular integrity through LRP1 and transforming growth factor-β signaling associated with increases of aortic PAI1.

Indexed as

Angiotensin IIProteomicsAnimalsDisease Models, AnimalHumansMiceMice, Inbred C57BLMice, KnockoutReceptor, Transforming Growth Factor-beta Type IIRNA, MessengerTransforming Growth FactorsAngiotensin IIReceptor, Transforming Growth Factor-beta Type IIRNA, MessengerTransforming Growth Factorsangiotensinaortic aneurysm, thoracicfibroblastmicesmooth muscle

Identifiers

PMID35143327
PMCPMC9008740
OpenAlexW4211003359

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.